Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Cancer prevention has advanced significantly, with some strategies proving successful.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Alpha 6 + /MHCI - cells have stem cell traits and are similar to mouse hair follicle stem cells.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Certain mutations in the KLHL24 gene cause a skin disorder by breaking down an important skin protein.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

EGFR deficiency causes significant changes in skin cells and hair follicles.

ILC1-like cells can cause alopecia areata by themselves.

New cancer drugs often cause skin and nail problems.

Recent advances show zebrafish can model anemia, Alx4 affects craniofacial and hair development, and mTORC1 is crucial for retinal development.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Suppressing eIF4E can prevent hair loss from chemotherapy.

miR-22 helps skin cancer grow and spread by activating specific cell signals.

Dimethylarsinic acid speeds up skin tumor growth in certain mice.

Collagen XVIII and Bmx tyrosine kinase are important for hair growth and skin cancer development.

FoxN1 overexpression in young mice harms immune cell and skin development.

B cells can both help and hinder the body's defense against melanoma.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Understanding EGFR roles could lead to new hair loss treatments.

New RIPK4 gene mutations were found to cause a type of skin and limb birth defect.

Certain gene variations may increase the risk of PCOS in South Indian women.

Sox9 is present in most canine skin tumors and may help understand stem cells' role in these cancers.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

A new genetic variant in the EEF2K gene may contribute to polycystic ovary syndrome.